Status:
RECRUITING
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
Lead Sponsor:
Hunan Province Tumor Hospital
Conditions:
Advanced Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a descriptive observational study in which data are collected in an epidemiological manner. This study is not intended to alter or interfere with the current medical practice of the enrolled p...
Eligibility Criteria
Inclusion
- Patients must be ≥18 years of age.
- Provision of fully informed consent prior to any study specific procedures.
- Histologically or cytologically confirmed, unresectable stage IIIB/IIIC or stage IV NSCLC.
- Genetic variants of tumor tissue detected by NGS.
Exclusion
- None.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06183762
Start Date
January 1 2020
End Date
June 30 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunan Province Tumor Hospital
Changsha, Hunan, China